Vicarious Surgical Inc. (NYSE:RBOT) Sees Large Drop in Short Interest

Vicarious Surgical Inc. (NYSE:RBOT) saw a significant decrease in short interest in the month of December. As of December 31st, there was short interest totaling 140,432 shares, a decrease of 32.3% from the December 15th total of 207,502 shares. Based on an average daily volume of 110,484 shares, the days-to-cover ratio is currently 1.3 days. Approximately 2.4% of the company’s stock are short sold. Approximately 2.4% of the company’s stock are short sold. Based on an average daily volume of 110,484 shares, the days-to-cover ratio is currently 1.3 days.

Vicarious Surgical Stock Performance

RBOT traded down $0.19 during mid-day trading on Friday, reaching $2.68. 79,954 shares of the stock were exchanged, compared to its average volume of 175,721. Vicarious Surgical has a 1 year low of $1.80 and a 1 year high of $16.92. The stock has a market capitalization of $17.52 million, a PE ratio of -0.30 and a beta of 1.52. The company has a 50 day moving average price of $2.71 and a two-hundred day moving average price of $5.56.

Vicarious Surgical (NYSE:RBOT) last announced its earnings results on Wednesday, November 12th. The company reported ($1.91) EPS for the quarter, beating the consensus estimate of ($2.37) by $0.46. Sell-side analysts expect that Vicarious Surgical will post -10.89 EPS for the current fiscal year.

Hedge Funds Weigh In On Vicarious Surgical

A number of hedge funds and other institutional investors have recently modified their holdings of the business. DNB Asset Management AS grew its stake in shares of Vicarious Surgical by 12.1% during the 2nd quarter. DNB Asset Management AS now owns 29,199 shares of the company’s stock worth $219,000 after acquiring an additional 3,154 shares during the period. Dimensional Fund Advisors LP lifted its holdings in Vicarious Surgical by 22.1% during the third quarter. Dimensional Fund Advisors LP now owns 19,975 shares of the company’s stock valued at $110,000 after purchasing an additional 3,615 shares during the last quarter. Finally, Connective Capital Management LLC purchased a new stake in Vicarious Surgical during the third quarter valued at about $169,000. Hedge funds and other institutional investors own 47.27% of the company’s stock.

Wall Street Analyst Weigh In

RBOT has been the subject of a number of recent research reports. Weiss Ratings restated a “sell (e+)” rating on shares of Vicarious Surgical in a research note on Wednesday, October 8th. BTIG Research reiterated a “neutral” rating on shares of Vicarious Surgical in a report on Friday, December 12th. Finally, Wall Street Zen upgraded shares of Vicarious Surgical from a “sell” rating to a “hold” rating in a report on Saturday, January 10th. Two investment analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Vicarious Surgical currently has an average rating of “Reduce” and a consensus price target of $7.00.

Vicarious Surgical Company Profile

Vicarious Surgical develops a next-generation robotic surgical system that integrates virtual reality (VR) with minimally invasive instrumentation. Its flagship offering combines ultra-slender, articulated robotic arms with a VR surgeon console, allowing physicians to perform laparoscopic procedures with enhanced precision, dexterity and visual immersion. The platform is designed to reduce patient trauma compared with traditional open or laparoscopic surgery and to expand surgeon access to challenging operative sites.

The company’s technology is intended for use across multiple surgical specialties, including general surgery, gynecology and urology.